Alkermes ALKS
NASDAQ ALKS
$45.34 -0.15 (-0.33%)
As of: Sep 9, 2026 · 3:37 PM EDT

Alkermes (ALKS) Other Non Operating Income (2010 - 2026)

Alkermes' (ALKS) quarterly Other Non Operating Income came in at $352000.0 in Q2 2026, down 54.35% year-over-year from $771000.0 in Q2 2025, and up 127.22% quarter-over-quarter from -$1.3 million in Q1 2026.

Analysis

Alkermes (ALKS) Other Non Operating Income (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Other Non Operating Income for 17 consecutive years, with $352000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non Operating Income fell 54.35% year-over-year to $352000.0 in Q2 2026; TTM through Jun 2026 was $3.7 million, a 53.12% decrease from a year earlier, with the FY2025 full-year figure at $7.0 million, down 10.75% from the prior year.
  • Other Non Operating Income was $352000.0 for Q2 2026 at Alkermes, up from -$1.3 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $5.4 million in Q4 2023 and troughed at -$5.4 million in Q4 2022.
  • A 5-year average of $877500.0 and a median of $455000.0 in 2024 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 915.32% in 2022, down 746.18% in 2022.
  • Over 5 years, Other Non Operating Income stood at -$5.4 million in 2022, then soared by 199.65% to $5.4 million in 2023, then declined by 6.5% to $5.0 million in 2024, then slipped by 1.87% to $4.9 million in 2025, then sank by 92.86% to $352000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $352000.0 (Q2 2026), -$1.3 million (Q1 2026), and $4.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.50 Bn 624.74 Bn 17.26 Bn
2 AbbVie 443.58 Bn 437.01 Bn 12.70 Bn
3 Merck 365.15 Bn 358.01 Bn 12.21 Bn
4 Novartis Ag 266.63 Bn 258.94 Bn 11.24 Bn
5 Pfizer 158.52 Bn 146.82 Bn 10.94 Bn
6 Sanofi 52.37 Bn 44.99 Bn 10.79 Bn
7 Revolution Medicines 43.95 Bn 43.95 Bn -
8 Incyte 25.37 Bn 20.83 Bn 1.57 Bn
9 United Therapeutics 21.56 Bn 18.90 Bn 683.80 Mn
10 Alkermes 7.57 Bn 6.92 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 352,000.00
Mar 31, 2026 -1.29 Mn
Dec 31, 2025 4.93 Mn
Sep 30, 2025 -280,000.00
Jun 30, 2025 771,000.00
Mar 31, 2025 1.56 Mn
Dec 31, 2024 5.02 Mn
Sep 30, 2024 558,000.00
Jun 30, 2024 2.05 Mn
Mar 31, 2024 182,000.00
Dec 31, 2023 5.37 Mn
Sep 30, 2023 149,000.00
Jun 30, 2023 -525,000.00
Mar 31, 2023 -39,000.00
Dec 31, 2022 -5.39 Mn
Sep 30, 2022 -1.86 Mn
Jun 30, 2022 1.81 Mn
Mar 31, 2022 2.43 Mn
Dec 31, 2021 5.49 Mn
Sep 30, 2021 288,000.00